Literature DB >> 22687977

[Reference guide for management of adult idiopathic thrombocytopenic purpura (ITP) 2012 version].

Kingo Fujimura, Yoshitaka Miyakawa, Yoshiyuki Kurata, Masataka Kuwana, Yoshiaki Tomiyama, Mitsuru Murata.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22687977

Source DB:  PubMed          Journal:  Rinsho Ketsueki        ISSN： 0485-1439


× No keyword cloud information.
  7 in total

1.  A low birth weight infant with no malformations delivered by a primary immune thrombocytopenia patient treated with eltrombopag.

Authors:  Naruko Suzuki; Junji Hiraga; Yumi Hariyama; Yusuke Takagi; Haruhiko Ohashi; Yasuyuki Kishigami; Hidenori Oguchi; Yoshitoyo Kagami
Journal:  Int J Hematol       Date:  2017-11-29       Impact factor: 2.490

2.  Successful early romiplostim use in a case of severe immune thrombocytopenia with critical carotid arterial injury.

Authors:  Reiko Watanabe; Takayuki Tabayashi; Tatsuki Tomikawa; Morihiko Sagawa; Tomoe Anan-Nemoto; Yuta Kimura; Yasuyuki Takahashi; Michihide Tokuhira; Satoshi Otaki; Hidenori Oi; Makoto Sawano; Satoshi Sugiyama; Masahiro Kizaki
Journal:  Int J Hematol       Date:  2016-10-05       Impact factor: 2.490

Review 3.  Helicobacter pylori-associated immune thrombocytopenia: clinical features and pathogenic mechanisms.

Authors:  Masataka Kuwana
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

4.  Oral eltrombopag for up to three years is safe and well-tolerated in Japanese patients with previously treated chronic immune thrombocytopenia: an open-label, extension study.

Authors:  Shinya Katsutani; Yoshiaki Tomiyama; Akiro Kimura; Yoshitaka Miyakawa; Shinichiro Okamoto; Yasushi Okoshi; Haruhiko Ninomiya; Hiroshi Kosugi; Kazuyoshi Ishii; Yasuo Ikeda; Toshihiro Hattori; Koichi Katsura; Yuzuru Kanakura
Journal:  Int J Hematol       Date:  2013-07-30       Impact factor: 2.490

5.  Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults.

Authors:  Kayoko Kikuchi; Yoshitaka Miyakawa; Shunya Ikeda; Yuji Sato; Toru Takebayashi
Journal:  BMC Health Serv Res       Date:  2015-01-22       Impact factor: 2.655

Review 6.  Platelet desialylation and TFH cells-the novel pathway of immune thrombocytopenia.

Authors:  Yuwen Chen; Jianda Hu; Yingyu Chen
Journal:  Exp Hematol Oncol       Date:  2021-03-15

7.  The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood.

Authors:  Seiichi Kato; Toshiaki Shimizu; Shigeru Toyoda; Benjamin D Gold; Shinobu Ida; Takashi Ishige; Shigeru Fujimura; Shigeru Kamiya; Mutsuko Konno; Kentaro Kuwabara; Kosuke Ushijima; Norikazu Yoshimura; Yoshiko Nakayama
Journal:  Pediatr Int       Date:  2020-12       Impact factor: 1.524
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.